Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
PLoS One. 2010 Oct 13;5(10):e13249. doi: 10.1371/journal.pone.0013249.
The entry of human immunodeficiency virus (HIV-1) into host cells involves the interaction of the viral exterior envelope glycoprotein, gp120, and receptors on the target cell. The HIV-1 receptors are CD4 and one of two chemokine receptors, CCR5 or CXCR4.
METHODOLOGY/PRINCIPAL FINDINGS: We created proteoliposomes that contain CD4, the primary HIV-1 receptor, and one of the coreceptors, CXCR4. Antibodies against CD4 and CXCR4 specifically bound the proteoliposomes. CXCL12, the natural ligand for CXCR4, and the small-molecule CXCR4 antagonist, AMD3100, bound the proteoliposomes with affinities close to those associated with the binding of these molecules to cells expressing CXCR4 and CD4. The HIV-1 gp120 exterior envelope glycoprotein bound tightly to proteoliposomes expressing only CD4 and, in the presence of soluble CD4, bound weakly to proteoliposomes expressing only CXCR4. The thermal stability of CD4 and CXCR4 inserted into liposomes was examined. Thermal denaturation of CXCR4 followed second-order kinetics, with an activation energy (E(a)) of 269 kJ/mol (64.3 kcal/mol) and an inactivation temperature (T(i)) of 56°C. Thermal inactivation of CD4 exhibited a reaction order of 1.3, an E(a) of 278 kJ/mol (66.5 kcal/mol), and a T(i) of 52.2°C. The second-order denaturation kinetics of CXCR4 is unusual among G protein-coupled receptors, and may result from dimeric interactions between CXCR4 molecules.
CONCLUSIONS/SIGNIFICANCE: Our studies with proteoliposomes containing the native HIV-1 receptors allowed an examination of the binding of biologically important ligands and revealed the higher-order denaturation kinetics of these receptors. CD4/CXCR4-proteoliposomes may be useful for the study of virus-target cell interactions and for the identification of inhibitors.
人类免疫缺陷病毒(HIV-1)进入宿主细胞涉及病毒外膜糖蛋白 gp120 与靶细胞上受体的相互作用。HIV-1 的受体是 CD4 和两种趋化因子受体之一,即 CCR5 或 CXCR4。
方法/主要发现:我们构建了含有 CD4(HIV-1 的主要受体)和一个辅助受体 CXCR4 的脂蛋白体。针对 CD4 和 CXCR4 的抗体特异性结合脂蛋白体。CXCR4 的天然配体 CXCL12 和小分子 CXCR4 拮抗剂 AMD3100 与脂蛋白体的结合亲和力接近与表达 CXCR4 和 CD4 的细胞结合这些分子的亲和力。仅表达 CD4 的脂蛋白体与 HIV-1 gp120 外膜糖蛋白紧密结合,而在存在可溶性 CD4 的情况下,仅表达 CXCR4 的脂蛋白体与 gp120 结合较弱。我们检测了插入脂质体中的 CD4 和 CXCR4 的热稳定性。CXCR4 的热变性遵循二级反应动力学,活化能(E(a))为 269 kJ/mol(64.3 kcal/mol),失活温度(T(i))为 56°C。CD4 的热失活表现出反应级数为 1.3,活化能(E(a))为 278 kJ/mol(66.5 kcal/mol),失活温度(T(i))为 52.2°C。CXCR4 的二级变性动力学在 G 蛋白偶联受体中较为罕见,可能是由于 CXCR4 分子之间的二聚相互作用所致。
结论/意义:我们使用含有天然 HIV-1 受体的脂蛋白体进行的研究允许检查生物重要配体的结合,并揭示了这些受体的高阶变性动力学。CD4/CXCR4-脂蛋白体可能有助于研究病毒-靶细胞相互作用和鉴定抑制剂。